Vid, first line may depend on the result of the lower dose trials. If it's successful, I could see a cascading effect on the 7 cancer indications currently in P2 trials or a domino effect faster than they could handle it, plus all the budding indications mentioned recently not on trial yet.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.